232 related articles for article (PubMed ID: 31600334)
1. Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells.
Lu S; Dong Z
PLoS One; 2019; 14(10):e0223894. PubMed ID: 31600334
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer.
Dillehay KL; Lu S; Dong Z
Mol Cancer Ther; 2014 Dec; 13(12):2817-26. PubMed ID: 25253786
[TBL] [Abstract][Full Text] [Related]
3. P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation.
Soria G; Podhajcer O; Prives C; Gottifredi V
Oncogene; 2006 May; 25(20):2829-38. PubMed ID: 16407842
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells.
Balajee AS; Dianova I; Bohr VA
Nucleic Acids Res; 1999 Nov; 27(22):4476-82. PubMed ID: 10536158
[TBL] [Abstract][Full Text] [Related]
5. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.
Inoue A; Kikuchi S; Hishiki A; Shao Y; Heath R; Evison BJ; Actis M; Canman CE; Hashimoto H; Fujii N
J Biol Chem; 2014 Mar; 289(10):7109-7120. PubMed ID: 24474685
[TBL] [Abstract][Full Text] [Related]
6. Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells.
Balajee AS; Geard CR
Nucleic Acids Res; 2001 Mar; 29(6):1341-51. PubMed ID: 11239001
[TBL] [Abstract][Full Text] [Related]
7. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
[TBL] [Abstract][Full Text] [Related]
8. UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells.
Riva F; Zuco V; Vink AA; Supino R; Prosperi E
Carcinogenesis; 2001 Dec; 22(12):1971-8. PubMed ID: 11751427
[TBL] [Abstract][Full Text] [Related]
9. PCNA-dependent accumulation of CDKN1A into nuclear foci after ionizing irradiation.
Wiese C; Rudolph JH; Jakob B; Fink D; Tobias F; Blattner C; Taucher-Scholz G
DNA Repair (Amst); 2012 May; 11(5):511-21. PubMed ID: 22456500
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
Actis M; Inoue A; Evison B; Perry S; Punchihewa C; Fujii N
Bioorg Med Chem; 2013 Apr; 21(7):1972-7. PubMed ID: 23395113
[TBL] [Abstract][Full Text] [Related]
11. Efficient PCNA complex formation is dependent upon both transcription coupled repair and genome overall repair.
Balajee AS; May A; Dianova I; Bohr VA
Mutat Res; 1998 Dec; 409(3):135-46. PubMed ID: 9875289
[TBL] [Abstract][Full Text] [Related]
12. Detection of chromatin-bound PCNA in mammalian cells and its use to study DNA excision repair.
Miura M
J Radiat Res; 1999 Mar; 40(1):1-12. PubMed ID: 10408173
[TBL] [Abstract][Full Text] [Related]
13. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
[TBL] [Abstract][Full Text] [Related]
14. Analysis of repair and PCNA complex formation induced by ionizing radiation in human fibroblast cell lines.
Karmakar P; Balajee AS; Natarajan AT
Mutagenesis; 2001 May; 16(3):225-32. PubMed ID: 11320148
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal dynamics of p21CDKN1A protein recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen.
Perucca P; Cazzalini O; Mortusewicz O; Necchi D; Savio M; Nardo T; Stivala LA; Leonhardt H; Cardoso MC; Prosperi E
J Cell Sci; 2006 Apr; 119(Pt 8):1517-27. PubMed ID: 16551699
[TBL] [Abstract][Full Text] [Related]
17. p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites.
Stivala LA; Riva F; Cazzalini O; Savio M; Prosperi E
Oncogene; 2001 Feb; 20(5):563-70. PubMed ID: 11313988
[TBL] [Abstract][Full Text] [Related]
18. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation.
Cardano M; Tribioli C; Prosperi E
Curr Cancer Drug Targets; 2020; 20(4):240-252. PubMed ID: 31951183
[TBL] [Abstract][Full Text] [Related]
19. Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance.
Vanarotti M; Evison BJ; Actis ML; Inoue A; McDonald ET; Shao Y; Heath RJ; Fujii N
Bioorg Med Chem; 2018 May; 26(9):2345-2353. PubMed ID: 29598900
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth.
Tan Z; Wortman M; Dillehay KL; Seibel WL; Evelyn CR; Smith SJ; Malkas LH; Zheng Y; Lu S; Dong Z
Mol Pharmacol; 2012 Jun; 81(6):811-9. PubMed ID: 22399488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
